Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow SOLV
Solventum Corporation (SOLV) Current ratio
Solventum Corporation's current ratio at the end of the quarter to 30 June 2026 was 1.0×, down 0.2× from fiscal 2025 (1.2×). That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.2× | 2.37% |
| FY2024 | 1.2× | (17.55%) |
| FY2023 | 1.5× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 1.0× | (4.62%) |
| Mar 2026 | 1.1× | (12.98%) |
| Dec 2025 | 1.2× | (17.97%) |
| Sep 2025 | 1.5× | 22.51% |
| 7 more quarters | Free account |
Current ratio against peers
| Company | Current ratio |
|---|---|
| RGEN Repligen Corporation compare | 9.1× |
| WST West Pharmaceutical Services, Inc. compare | 2.8× |
| ALC Alcon compare | 2.1× |
| BAX Baxter International Inc. compare | 1.9× |
| AVTR Avantor, Inc. compare | 1.8× |
| ATR AptarGroup, Inc. compare | 1.6× |
| ALGN Align Technology, Inc. compare | 1.4× |
| COO The Cooper Companies, Inc. compare | 1.2× |
| SOLV Solventum Corporation | 1.0× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement